Home > Insider Trading > Filing (0001209191-11-043226)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341637	Alison Kiley	One Embarcadero Center Suite 3700 San Francisco CA 94111		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-08	4,200	$12.43	2,684,751	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2011-08-09	5,500	$12.45	2,690,251	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,680,551	Indirect	See Footnotes

Footnotes

The reporting person is a member of Alta BioPharma Management III, LLC ("ABMIII"), which is the general partner of Alta BioPharma Partners III, L.P. ("ABPIII") and the managing limited partners of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). She may be deemed to share investment power over the securities of the Issuer held by ABPIII, ABPIIIKG, and Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII") with the directors of ABMIII and managers of AEBPIII but disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein.
On August 8, 2011, ABPIII, ABMPIIIKG, and AEBPIII acquired 3847, 258, and 95 shares of the Issuer's Common Stock, respectively, from the public market at an average price of $12.4296 per share.
On August 9, 2011, ABPIII, ABMPIIIKG, and AEBPIII acquired 5038, 338, and 124 shares of the Issuer's Common Stock, respectively, from the public market at an average price of $12.454 per share.